drugset / Trial / NCT01061190
Beta Blockers In Acute Ischemic Stroke
Phase 2/3
Completed
20 enrolled
Wilhelm Haverkamp
German Federal Ministry of Education and Research · collab
RandomizedParallel-groupQuadruple-blindPrevention
Summary
The objective of this trial is to assess the safety and efficacy of neuro- and cardioprotective effects of propranolol in acute ischemic stroke. Furthermore, exploratory analyses of cardiologic-electrophysiologic and immunologic parameters will be performed.
Timeline
- Start
- 2010-01
- Primary completion
- 2011-10
- Completion
- 2013-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Propranolol | Small molecule | 160 mg | Oral |